GlassScriptPhysician profile
Jeffrey D Downing
NPI 1982704243
$1,137.49
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $40.78 · 2021: $82.66 · 2022: $382 · 2023: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $413.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $262.86 | 2022-2023 | Ova1 |
| Abbvie INC. | $176.89 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Therapeuticsmd, INC. | $87.34 | 2019-2022 | |
| Pfizer INC. | $85.54 | 2019-2023 | |
| Astellas Pharma US INC | $83.32 | 2023 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $73.80 | 2020-2023 | Slynd |
| Organon LLC | $58.30 | 2022-2023 | Nexplanon |
| Shield Therapeutics INC | $56.10 | 2023 | Accrufer |
| Lsi Solutions INC | $50.40 | 2022-2023 | Fornisee |
| Minerva Surgical, INC | $46.99 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $42.39 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $25.34 | 2019 | |
| Amgen INC. | $21.93 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $16.38 | 2023 | Seglentis |
| Evofem Biosciences, INC. | $15.98 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $13.19 | 2019 | |
| Avion Pharmaceuticals | $11.71 | 2021 | |
| Meditrina | $9.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Downing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.